Nanjing Legend Biotech establishes global patent portfolio for CAR-T therapeutics
Clients Nanjing Legend Biotech Co., Ltd et al
Jones Day represents Nanjing Legend Biotech Co., Ltd et al in the development and prosecution of global patent portfolios related to chimeric antigen receptor T cell (CAR-T) and other cellular therapeutics, including certain clinical trial candidates.